Live Breaking News & Updates on Neogenomics

Stay informed with the latest breaking news from Neogenomics on our comprehensive webpage. Get up-to-the-minute updates on local events, politics, business, entertainment, and more. Our dedicated team of journalists delivers timely and reliable news, ensuring you're always in the know. Discover firsthand accounts, expert analysis, and exclusive interviews, all in one convenient destination. Don't miss a beat — visit our webpage for real-time breaking news in Neogenomics and stay connected to the pulse of your community

Aigen Investment Management LP Makes New Investment in NeoGenomics, Inc. (NASDAQ:NEO)

Aigen Investment Management LP acquired a new position in shares of NeoGenomics, Inc. (NASDAQ:NEO – Free Report) in the third quarter, according to its most recent disclosure with the SEC. The firm acquired 13,232 shares of the medical research company’s stock, valued at approximately $163,000. Other hedge funds also recently added to or reduced their […]

United-states , Kestra , Russia-general- , Russia , Aliciac-olivo , Piper-sandler , Skandinaviska-enskilda-banken , Neogenomics-company-profile , Neogenomics-inc , Kestra-advisory-services , Envestnet-asset-management-inc , Clinical-services

NeoGenomics (NASDAQ:NEO) Rating Reiterated by William Blair

William Blair reaffirmed their outperform rating on shares of NeoGenomics (NASDAQ:NEO – Free Report) in a research report report published on Wednesday, RTT News reports. William Blair also issued estimates for NeoGenomics’ Q1 2025 earnings at ($0.04) EPS, Q2 2025 earnings at ($0.03) EPS, Q3 2025 earnings at ($0.01) EPS, Q4 2025 earnings at $0.02 […]

United-states , Aliciac-olivo , William-blair , Burkett-financial-services , Morgan-stanley , Pharma-services , Neogenomics-inc , O-dell-group , Clinical-services , Coppell-advisory-solutions , Neogenomics-company-profile , Needham-company

NeoGenomics, Inc. (NASDAQ:NEO) General Counsel Sells $38,701.52 in Stock

NeoGenomics, Inc. (NASDAQ:NEO – Get Free Report) General Counsel Alicia C. Olivo sold 2,587 shares of the stock in a transaction dated Thursday, February 15th. The shares were sold at an average price of $14.96, for a total value of $38,701.52. Following the completion of the transaction, the general counsel now owns 34,866 shares of […]

United-states , Aliciac-olivo , William-blair , Neogenomics-inc , Neogenomics-company-profile , Alphacrest-capital-management , Citigroup-inc , Goldman-sachs-group , Clinical-services , Nasdaq , Pharma-services , Securities-exchange-commission

NeoGenomics (NEO) Q4 Earnings: How Key Metrics Compare to Wall Street Estimates

While the top- and bottom-line numbers for NeoGenomics (NEO) give a sense of how the business performed in the quarter ended December 2023, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.

Key-company-metrics-for-neogenomics , Clinical-services , Zacks-investment-research , Gross-clinical-services , Zacks-consensus-estimate , Wall-street , Key-company-metrics , Zacks-rank , Zacks-investment , Neogenomics , All-street-analysts

NeoGenomics (NASDAQ:NEO) Trading Up 3.6%

NeoGenomics, Inc. (NASDAQ:NEO – Get Free Report)’s share price traded up 3.6% during mid-day trading on Tuesday . The stock traded as high as $14.89 and last traded at $14.87. 230,588 shares changed hands during mid-day trading, a decline of 74% from the average session volume of 894,408 shares. The stock had previously closed at […]

Arizona , United-states , Morgan-stanley , Pharma-services , Nasdaq , Neogenomics-inc , Quadrant-capital-group , Clinical-services , Needham-company , Metlife-investment-management , Get-free-report

NeoGenomics Inc (NEO) Reports Growth in Revenue and Reduction in Net Loss for Q4 and Full Year 2023

NEO Sees 12% Quarterly Revenue Increase and 37% Decrease in Net Loss

Chris-smith , Diagnostics-research , Clinical-services , Neogenomics-inc , Financial-performance , Advanced-diagnostics , Medical-diagnostics , Neogenomics , Eo , Linical-services , Evenue-growth , Eogenomics-inc

Skandinaviska Enskilda Banken AB publ Invests $253,000 in NeoGenomics, Inc. (NASDAQ:NEO)

Skandinaviska Enskilda Banken AB publ bought a new position in shares of NeoGenomics, Inc. (NASDAQ:NEO – Free Report) during the 3rd quarter, according to the company in its most recent Form 13F filing with the SEC. The firm bought 20,500 shares of the medical research company’s stock, valued at approximately $253,000. Several other institutional investors […]

United-states , Skandinaviska-enskilda-banken , Nasdaq , Goldman-sachs-group , Morgan-stanley , Coppell-advisory-solutions , Tower-research-capital , Clinical-services , Needham-company , Pharma-services , Neogenomics-inc , Bluepath-capital-management

Illinois Municipal Retirement Fund Makes New $960,000 Investment in NeoGenomics, Inc. (NASDAQ:NEO)

Illinois Municipal Retirement Fund acquired a new position in NeoGenomics, Inc. (NASDAQ:NEO – Free Report) in the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor acquired 78,076 shares of the medical research company’s stock, valued at approximately $960,000. Illinois Municipal Retirement Fund owned approximately 0.06% […]

United-kingdom , Texas , United-states , Illinois , Aliciac-olivo , Piper-sandler , Mitsubishi-ufj , Neogenomics-inc , Exchange-commission , Asset-management-united-kingdom-ltd , Td-asset-management-inc , Pharma-services

Mitsubishi UFJ Asset Management UK Ltd. Raises Stake in NeoGenomics, Inc. (NASDAQ:NEO)

Mitsubishi UFJ Asset Management UK Ltd. lifted its holdings in NeoGenomics, Inc. (NASDAQ:NEO – Free Report) by 13.9% during the third quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 41,000 shares of the medical research company’s stock after acquiring an additional 5,000 shares during the quarter. […]

United-states , United-kingdom , Aliciac-olivo , Piper-sandler , Pharma-services , Goldman-sachs-group , Asset-management-united-kingdom-ltd , Morgan-stanley , Neogenomics-inc , Exchange-commission , Needham-company , Clinical-services

Perkins Capital Management Inc. Has $2.39 Million Holdings in NeoGenomics, Inc. (NASDAQ:NEO)

Perkins Capital Management Inc. cut its stake in shares of NeoGenomics, Inc. (NASDAQ:NEO – Free Report) by 1.3% in the third quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 193,950 shares of the medical research company’s stock after selling 2,550 shares during […]

United-states , Aliciac-olivo , Piper-sandler , Goldman-sachs-group , Citigroup-inc , Alphacrest-capital-management , Pharma-services , Commonwealth-of-pennsylvania-public-school-empls-retrmt , Morgan-stanley , Needham-company , Securities-exchange-commission , Neogenomics-company-profile